IMP321: Phase I/IIa data

An open-label, Swiss Phase I/IIa trial in 16 patients with metastatic melanoma showed that 5

Read the full 151 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE